Avidity Biosciences Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $56.00 on 11/13/24, while the lowest price during the same period was $13.01 on 02/13/24.
52-week price history of RNA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Avidity Biosciences Inc’s current trading price is -43.16% away from its 52-week high, while its distance from the 52-week low is 144.66%. The stock’s price range for this period has remained between $13.01 and $56.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.49 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.35 million over the last three months.
Financial Performance and Market Capitalization
Avidity Biosciences Inc (RNA) has experienced a quarterly decline of -31.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.80B and boasts a workforce of 253 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 39.03, with a change in price of -12.80. Similarly, Avidity Biosciences Inc recorded 1,293,686 in trading volume during the last 100 days, posting a change of -28.68%.
RNA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RNA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
RNA Stock Stochastic Average
As of today, the raw stochastic average of Avidity Biosciences Inc over the past 50 days is 30.23%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 53.98%. Additionally, the Stochastic %K and %D values for the company were 73.44% and 84.14%, respectively, over the past 20 days.
RNA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 9.46%. However, over the past six months, we’ve seen a stronger performance of -28.44%. The price of RNA fallen by 12.04% over the last 30 days. And in the last five days, it has fallen by -8.22%.
